background nitric oxide generally increased inflammatory airway diseases increased stimulates secretion mucin goblet cell submucosal glands mechanism unknown precisely study investigated potential signaling pathways involving protein kinase c pkc protein kinase mapk muc5ac mucin gene protein expression a549 cells methods nitric oxide donated a549 cells muc5ac mucin levels assayed immunosorbent assay elisa muc5ac promoter activity determined measuring luciferase activity lysing transfected cells activation pkc isoforms measured assessing distribution enzyme cytosolic membrane fractions using immunoblotting immunoblotting experiments using monoclonal antibody specific pkc isoforms performed cytosol membrane fractions a549 cells western blot analysis perk p38 performed using corresponding antibodies cell lysates donating a549 cells results transcriptional activity muc5ac promoter maximal concentration NUMBER mm NUMBER hour incubation transfected a549 cells nor1 markedly displaced protein kinase c pkcalpha pkcdelta cytosol membrane furthermore go6976 NUMBER nm pkcdelta inhibitors rottlerin NUMBER mum inhibited induced migration pkcalpha pkcdelta respectively markedly increased muc5ac promoter activity mrna expression mucin synthesis phosphorylation pkc inhibitors inhibited induced muc5ac mrna muc5ac protein synthesis inhibiting activation pkcalpha pkcdelta pathways conclusion exogenous induced muc5ac mucin gene protein pkcalpha pathways a549 cells inhibition pkc attenuated muc5ac mucin synthesis view findings pkc inhibitors useful treatment bronchial asthma chronic bronchitis patients mucus increased bronchial airways mitogen activated induced NUMBER enzyme linked NUMBER NUMBER e methyl NUMBER e hydroxyimino NUMBER nitro NUMBER methoxy NUMBER hexenamide pkc alphabetainhibitors NUMBER NUMBER NUMBER pkcdelta erk mediated erk1 NUMBER erk1 NUMBER